Fulgent Genetics, Inc. (FLGT) vs Personalis, Inc. (PSNL)
- Fulgent Genetics, Inc. FLGT 23.31 +24.92%
- Personalis, Inc. PSNL 15.79 +1.54%
Fulgent Genetics, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $513.4M — 3.3× the size. Personalis, Inc. grew revenue faster over the last twelve months: 16.9% against 4.67%. Fulgent Genetics, Inc. has the higher net margin (−27.5% vs −147.7%) and the higher return on invested capital (−8.22% vs −358.4%). Across the 17 metrics below, Fulgent Genetics, Inc. leads on 12 and Personalis, Inc. on 5.
Valuation
Profitability
| Metric | FLGT | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | 16.71% | 48.32% |
| Operating margin | (39.20%) | (156.66%) | (5.68%) |
| Net margin | (27.53%) | (147.74%) | (4.10%) |
| Free cash flow margin | 4.37% | (120.79%) | 0.00% |
| Return on equity | (8.64%) | (62.14%) | 0.00% |
| Return on assets | (7.93%) | (44.66%) | (6.05%) |
| Return on invested capital | (8.22%) | (358.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack